Treatments for Plaque Psoriasis

>

Latest News

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis
Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Results from the phase 3 DERMIS-1 and DERMIS-2 trials were presented at the 2023 American Academy of Dermatology Annual Meeting.

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis
Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis

September 10th 2022

psoriasis
Study: Risk of Psoriasis Related to BMI

December 21st 2021

psoriasis
Apremilast Use During COVID-19

December 21st 2021

Phase 3 Tapinarof Data Released
Phase 3 Tapinarof Data Released

December 8th 2021

Video Series
Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.